ICAHN CARL C
Institutional investor · Portfolio as of Q4 2024
Top Holdings14 positions
ICAHN ENTERPRISES LP | 450.8M | $3.9B | 52.7% | $14.15 | -59.50% | 25 qtrssince 2018-Q4 | Increased 68 |
CVR ENERGY INC | 66.7M | $1.2B | 16.9% | $19.52 | -4.60% | 25 qtrssince 2018-Q4 | Unchanged 0 |
SOUTHWEST GAS HOLDINGS INC | 9.6M | $681.1M | 9.2% | $62.21 | +9.26% | 14 qtrssince 2021-Q3 | Decreased 0 |
INTL FLAVORS & FRAGRANCES | 3.8M | $317.1M | 4.3% | $87.62 | -7.19% | 12 qtrssince 2022-Q1 | Unchanged 0 |
CVR PARTNERS LP | 4.1M | $308.9M | 4.2% | $59.18 | +3.24% | 4 qtrssince 2024-Q1 | Increased 62 |
BAUSCH HEALTH COS INC | 34.7M | $279.9M | 3.8% | $29.39 | -73.70% | 17 qtrssince 2020-Q4 | Unchanged 0 |
DANA INC | 14.3M | $165.2M | 2.2% | $20.31 | -44.86% | 17 qtrssince 2020-Q4 | Unchanged 0 |
JETBLUE AWYS CORP | 17.7M | $139.3M | 1.9% | $7.42 | +5.93% | 4 qtrssince 2024-Q1 | Unchanged 0 |
AMERICAN ELEC PWR CO INC | 1.2M | $111.2M | 1.5% | $73.72 | +18.18% | 5 qtrssince 2023-Q4 | Unchanged 0 |
CAESARS ENTERTAINMENT INC NE | 2.4M | $81.5M | 1.1% | $39.74 | -17.41% | 3 qtrssince 2024-Q2 | Unchanged 0 |
BAUSCH PLUS LOMB CORP | 3.5M | $63.2M | 0.9% | $15.28 | +16.43% | 11 qtrssince 2022-Q2 | Unchanged 0 |
SANDRIDGE ENERGY INC | 4.8M | $56.4M | 0.8% | $5.53 | +101.99% | 25 qtrssince 2018-Q4 | Unchanged 0 |
CENTURI HOLDINGS INC | 2.5M | $48M | 0.6% | $18.33 | +4.84% | 3 qtrssince 2024-Q2 | Decreased 0 |
ILLUMINA INC | 40,000 | $5.3M | 0.1% | $219.12 | -39.04% | 8 qtrssince 2023-Q1 | Decreased 0 |
ICAHN CARL C manages $7.4B across 14 positions as of Q4 2024. Top holdings: IEP (52.7%), CVI (16.9%), SWX (9.2%). Fund DNA: Concentrated Value. HoldingsIntel Score: 4/5.0.
Increased 2, trimmed 3. Top move: IEP (INCREASED, conviction 68). Portfolio: $7.4B across 14 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR